本文翻译正在准备中。在此之前，我们暂时显示英文原文。
商业 · 2026/7/231 分钟阅读
Prospective Grant of an Exclusive Patent License: RXFP1 AGONISTS
本地自动翻译 · 来源原始语言
摘要
The National Center for Advancing Translational Sciences, an institute of the National Institutes of Health, Department of Health and Human Services, is contemplating the grant of an Exclusive Patent License to practice the inventions embodied in the Patents and Patent Applications listed in the SUPPLEMENTARY INFORMATION section of this Notice to Modala Bio, Inc. (Modala), headquartered in Delaware.
来源原始语言: Federal Register — Health and Human Services打开原始公告 →